SynBioBeta Speaker
Christopher Bradley
Matter Bio
CEO
Chris Bradley is a serial entrepreneur with a background in neuroscience, cell biology and computer science. He has dedicated his career to founding and translating breakthrough biotechnology and healthcare technology companies that push the boundaries of what is possible. As part of his entrepreneurial journey, Chris has been involved at the earliest stages of company conception; whiteboarding technological solutions and in-sourcing academic IP, all the way through licensing, fundraising, conference main stage presentations and demos, crafting regulatory strategy, successful patent prosecution and issuing, industry partnerships and business development up to successful sale of his last company to a large multinational corporation. He is currently CEO & Co-Founder of Matter Bio, a DNA repair company. When he’s not obsessing about DNA damage, he can usually be found chasing his condiment covered toddler through the house or working on his 1956 Panhead chopper project.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Christopher
This Year
Session lineup still growing
Purchase Pass
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Purchase Pass
Featuring
Speaker Coming Soon
